Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
3.800
+0.070 (1.88%)
Dec 20, 2024, 4:00 PM EST - Market closed
Marker Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Cash & Equivalents | 9 | 15.11 | 11.78 | 42.35 | 21.35 | 43.9 | Upgrade
|
Cash & Short-Term Investments | 9 | 15.11 | 11.78 | 42.35 | 21.35 | 43.9 | Upgrade
|
Cash Growth | -48.50% | 28.26% | -72.18% | 98.34% | -51.37% | -28.90% | Upgrade
|
Other Receivables | 0.74 | 1.03 | 2.4 | 0 | 1 | 0.06 | Upgrade
|
Receivables | 0.74 | 1.03 | 2.4 | 0 | 1 | 0.06 | Upgrade
|
Prepaid Expenses | 1.17 | 0.99 | 1.85 | 2.48 | 2.06 | 1.53 | Upgrade
|
Restricted Cash | - | - | - | 1.15 | - | - | Upgrade
|
Other Current Assets | - | - | 0.59 | - | - | - | Upgrade
|
Total Current Assets | 10.91 | 17.13 | 16.62 | 45.98 | 24.41 | 45.49 | Upgrade
|
Property, Plant & Equipment | - | - | - | 22.15 | 21.2 | 0.87 | Upgrade
|
Other Long-Term Assets | - | - | 17.8 | - | - | - | Upgrade
|
Total Assets | 10.91 | 17.13 | 34.42 | 68.14 | 45.61 | 46.36 | Upgrade
|
Accounts Payable | 1.9 | 0.96 | 1.1 | 5.14 | 2.94 | 0.99 | Upgrade
|
Accrued Expenses | 1.35 | 1.91 | 1.27 | 3.33 | 2.95 | 0.52 | Upgrade
|
Current Portion of Leases | - | - | - | 0.62 | 0.39 | 0.2 | Upgrade
|
Current Unearned Revenue | - | - | - | 1.15 | - | - | Upgrade
|
Other Current Liabilities | 0.2 | 0.21 | 5.41 | 2.66 | 0.13 | 0.27 | Upgrade
|
Total Current Liabilities | 3.46 | 3.07 | 7.78 | 12.9 | 6.4 | 1.99 | Upgrade
|
Long-Term Leases | - | - | - | 11.25 | 11.87 | 0.28 | Upgrade
|
Other Long-Term Liabilities | - | - | 7.04 | - | - | - | Upgrade
|
Total Liabilities | 3.46 | 3.07 | 14.82 | 24.15 | 18.27 | 2.27 | Upgrade
|
Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.05 | 0.05 | Upgrade
|
Additional Paid-In Capital | 450.62 | 450.33 | 447.64 | 442.1 | 383.53 | 371.57 | Upgrade
|
Retained Earnings | -443.18 | -436.29 | -428.05 | -398.12 | -356.24 | -327.53 | Upgrade
|
Shareholders' Equity | 7.45 | 14.05 | 19.6 | 43.99 | 27.34 | 44.09 | Upgrade
|
Total Liabilities & Equity | 10.91 | 17.13 | 34.42 | 68.14 | 45.61 | 46.36 | Upgrade
|
Total Debt | - | - | - | 11.87 | 12.26 | 0.48 | Upgrade
|
Net Cash (Debt) | 9 | 15.11 | 11.78 | 30.48 | 9.1 | 43.42 | Upgrade
|
Net Cash Growth | -48.50% | 28.26% | -61.35% | 235.15% | -79.05% | -29.68% | Upgrade
|
Net Cash Per Share | 1.01 | 1.72 | 1.41 | 3.98 | 1.93 | 9.52 | Upgrade
|
Filing Date Shares Outstanding | 8.92 | 8.9 | 8.8 | 8.31 | 5.07 | 4.65 | Upgrade
|
Total Common Shares Outstanding | 8.92 | 8.89 | 8.41 | 8.31 | 5.07 | 4.57 | Upgrade
|
Working Capital | 7.45 | 14.05 | 8.84 | 33.08 | 18.01 | 43.49 | Upgrade
|
Book Value Per Share | 0.83 | 1.58 | 2.33 | 5.29 | 5.39 | 9.64 | Upgrade
|
Tangible Book Value | 7.45 | 14.05 | 19.6 | 43.99 | 27.34 | 44.09 | Upgrade
|
Tangible Book Value Per Share | 0.83 | 1.58 | 2.33 | 5.29 | 5.39 | 9.64 | Upgrade
|
Machinery | - | - | - | 9.66 | 3.87 | 0.5 | Upgrade
|
Construction In Progress | - | - | - | 2.23 | 6.79 | - | Upgrade
|
Leasehold Improvements | - | - | - | 3.17 | 0.29 | 0.02 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.